Biogen bags FDA nod for high dose SPINRAZA in spinal muscular atrophy
Biogen to buy Apellis Pharmaceuticals for $5.6B in rare disease and immunology push
Orca Bio’s Orca-T FDA review extended to July 2026
Emcure Pharma reduces Poviztra starting dose price by 55% in India
Agilent opens new customer experience center in Mumbai
Lupin completes acquisition of VISUfarma
Bayer plans to offer Eylea 2mg at lower cost in India for benefit of retinal disease patients
FDA okays Eli Lilly’s new weight-loss pill, expanding options for millions
Vyome Holdings bolsters financial position to support VT-1953 pivotal study through 2027
D2C nutrition brand BeastLife raises Rs 20 crore at Rs 320 crore valuation from GVFL and Equentis
The impact on Phase III trials is particularly significant, as these later-stage studies involve larger, committed patient populations and represent years of investment
Subscribe To Our Newsletter & Stay Updated
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The complexity of compliance
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes
.jpg?v=1775157812)
